Cat Vaccines: Which Ones Your Cat Actually Needs

The Schedule That Changes When Your Cat Never Goes Outside

A strictly indoor cat and a cat with outdoor access have genuinely different vaccine risk profiles. The core vaccines -- FVRCP and rabies -- are recommended for every cat regardless of lifestyle because rabies is legally required, panleukopenia is so environmentally persistent that even an indoor cat is theoretically exposed, and FHV-1 and calicivirus exposures can occur from clothing, shared airflow, or a single escape. Beyond the cores, the appropriate non-core vaccines depend heavily on whether the cat goes outside.

FeLV (feline leukemia virus) vaccine is recommended for all kittens and for adult cats with outdoor access or multi-cat household exposure to cats of unknown FeLV status -- the disease is transmitted by prolonged close contact, grooming, and shared food and water bowls, and there is no cure. An indoor adult cat with no outdoor access or new cat introductions is at lower risk, and some guidelines allow discontinuing FeLV vaccination in stable, exclusively indoor adult cats after age 3-4.

The Kitten Series and Why the Last Dose Is the One That Counts

The kitten FVRCP series (3-4 doses at 3-4 week intervals starting at 6-8 weeks, with the final dose at or after 16 weeks) follows the same maternal antibody interference logic as puppies. The single most common kitten vaccination gap is finishing the series too early -- a final FVRCP at 12 weeks may have been blocked by residual maternal antibodies, leaving the kitten susceptible. If the final kitten dose was given before 16 weeks, the vaccine should be repeated at 16 weeks or later.

Kitten FeLV is given as a 2-dose primary series, 3-4 weeks apart, starting at 8 weeks. Rabies is given as a single dose as early as 12 weeks (brand-specific), followed by a booster at 1 year, then according to product label (1-year or 3-year product determines subsequent interval).

Injection Site Sarcoma: The Feline Vaccine-Specific Risk

Cats develop injection site sarcomas (ISS) -- aggressive fibrosarcomas -- at rates of approximately 1 per 1,000-10,000 vaccinated cats. ISS is associated with inflammation at injection sites, which is why current AAFP guidelines recommend specific anatomical sites for each vaccine (rabies in the right rear limb, FeLV in the left rear limb, FVRCP between the shoulder blades, though distally is now preferred over the interscapular region) to allow early detection and complete surgical removal if sarcoma develops.

Any lump at a vaccine site that persists beyond 3 months, is larger than 2 cm, or continues to grow after 1 month should be biopsied -- this is the AAFP's '1-2-3 rule' for vaccine site lump evaluation. Earlier diagnosis and complete first excision dramatically improve outcomes for ISS, which has a median recurrence time of 6 months after incomplete excision.

The 3-Year Adult Schedule and Titer Options

Adult cats that completed the kitten series and received a 1-year booster are eligible for a 3-year FVRCP schedule per AAFP Feline Vaccination Advisory Panel guidelines. Duration of immunity studies show that FVRCP vaccines in adult cats provide protective immunity for at least 3 years in most cats. Rabies vaccine intervals are determined by product label and state law.

Titer testing for FVRCP components (particularly panleukopenia) is available and is accepted by AAFP as an alternative to automatic 3-year revaccination in adult cats. Cats with protective panleukopenia titers do not need FVRCP revaccination by immunological standards, though rabies boosters must follow legal requirements regardless of titer results.